Dansk Kræftforskningsfonds uddeling i 2024: Kr. 4.000.000
Ms Zijun Quan, BRIC, University of Copenhagen
Project: New aspects of BRCA2 function in tumor suppression- kr. 250.000
Ms Sara Blaabjerg Artzi, The Bartholin Institute, the Department of Pathology, Rigshospitalet
Project: Exploring the impact of the urinary, tumor and gut microbiome in bladder cancer treatment and outcome - kr. 250.000
Ms Julie Rasmussen, Department of Molecular Medicine, Aarhus University
Project: Clinical and molecular characterization of childhood acute myeloid leukemia with myelodysplasia-related cytogenetic abnormalities - kr. 250.000
Ms Stine Bitsch-Olsen, Department of Hematology, Rigshospitalet
Project: HemEx: Exercise as potential therapeutic strategy for patients with early myeloid malignancy or predisposition to this - kr. 250.000
Mr Martin Kjær Simonsen, Department of Pathology, Aarhus University
Project: Characterization of recurrence patterns after ductal carcinoma in situ in the breast in all Danish women from 2008-2023: a population-based cohort study - kr. 250.000
Ms Christiane Sophie Staxen, Department of Hematology, Zealand University Hospital
Project: Characteristics and clinical implications of the gut microbiota in diffuse large B-cell lymphoma - kr. 250.000
Ms Sara Fresnillo Saló, Center for Cancer Immunotherapy, CCIT, Herlev Hospital
Project: Exercise as combination partner for immune therapy of cancer - kr. 225.000
Ms Laura Elgaard Iisager Jensen, Department of Molecular Medicine, Aarhus University Hospital
Project: IMMUNCIRC: Investigating the role of the immune system in immunotherapy response and the use of circulating tumor DNA-guided patient management in renal cancer - kr. 176.250
Ms Marie Øbo, Department of Plastic Surgery, Aarhus University Hospital
Project: A comprehensive analysis of perioperative fibrinolysis, inflammation and the gut microbiome as novel prognostic and predictive biomarkers in melanoma; PRIME-translational - kr. 176.250
Ms Benedetta Policastro, Molecular Medicine, Cancer Research Unit, University of Southern Denmark
Project: Patient-derived models for optimized treatment selection in breast cancer - kr. 176.250
.
Ms Signe Bülow Therkildsen, University Research Clinic for Cancer Screening
Project: OPTIMIZED-FIT: Optimization of the Danish National FIT-based colorectal cancer screening program - kr. 176.250
Ms Emma Neble Larsen, Cancer Survivorship, Danish Cancer Institute
Project: Towards equity in cancer care: Improving access to cancer care in patients with ethnic minority background - kr. 176.250
Ms Majken Mondrup Hjelt, Department of Oncology, Aarhus University Hospital
Project: Selecting the right patient in due time for enteral feeding tube and optimizing trans-sectoral support - A study in patients with head and neck cancer - kr. 160.000
Ms Anna Røssberg Lauridsen, Cancer Invasion and Resistance, Kræftens Bekæmpelse
Project: Improving the survival of HGSC patients with fast relapsing disease - kr. 176.250
Ms Katharina Wolter, Department of Hematology, Aarhus University Hospital
Project: Gene therapy for childhood malignancies driven by fusion oncogenes - kr. 176.250
Mr Kristian Egebjerg, Department of cancer treatment
Project: Expanding the indication of HER2 targeted treatment in solid tumors - kr. 176.250
Ms Cathrine Korsholm, Department of Clinical Pharmacology
Project: Investigating the relationship between drug concentrations of ibrutinib (targeted anti-cancer drug), CYP3A4 activity, efficacy, and safety in patients with chronic lymphocytic leukemia - kr. 176.250
Ms Helena Brøckner, Health Science and Technology, Aalborg University
Project: Novel Method for Early Detection of Chemotherapy-induced Peripheral Neuropathy - kr. 176,.250
Ms Rosi Krebs, Biotech Research & Innovation Centre (BRIC), University of Copenhagen
Project: Investigating the role of cancer-relevant ribosomal RNA 2’-O-methylations - kr. 176.250
Ms Sarah Eckholdt Jensen, Danish Center for particle Therapy, Aarhus University Hospital
Project: Translational Research in the International Randomized Photon Versus Proton (PROTECT) Trial for Locally Advanced Esophageal Cancer - kr. 176.250